miR-106b-5p作为癌症进展和化疗诱导心脏毒性的中央调节剂:从分子机制到临床翻译
Maria Del Carmen Asensio Lopez1,2,3, Miriam Ruiz Ballester2, Francisco Jose Bastida Nicolas2
1R&D Department, Biocardio S.L., El Palmar, 30120 Murcia, Spain.
International journal of molecular sciences
|October 29, 2025
概括
微RNA-106b-5p驱动癌症生长和多克索鲁比诱导的心脏损伤. 一种新的疗法,AM106,有效地向这种微RNA,提供对癌症和心脏毒性的双重保护.
科学领域:
- 心脏瘤学 - 心脏瘤学
- 分子生物学分子生物学
- 发现生物标志物的发现.
背景情况:
- 微RNAs (miRNAs) 调节癌症和心血管疾病中的基因表达.
- miR-106b-5p是一种致癌的miRNA,涉及各种癌症.
- 它在环素诱导的心脏毒性中的作用是最近的一项发现.
研究的目的:
- 审查miR-106b-5p在瘤进展和化疗诱导的心脏功能障碍中的双重作用.
- 提供证据证明miR-106b-5p在多克索鲁比诱导的心脏毒性中的作用.
- 引入AM106,一种针对miR-106b-5p的新型抗体.
主要方法:
- 在癌症和心脏毒性中对miR-106b-5p的文献综述.
- 在 doxorubicin 诱导心脏毒性的模型中对 AM106 反对米尔进行临床前研究.
- 探索用于生物标志物识别的人工智能 (AI) 应用.
主要成果:
- 在多种癌症中,miR-106b-5p被上调,通过抑制瘤抑制剂来促进瘤发生.
- miR-106b-5p在多克索鲁比辛治疗后的心肌中被上调,导致左心室功能障碍.
- AM106在不影响抗瘤功效的情况下预防心脏损伤,恢复关键蛋白质活动.
结论:
- miR-106b-5p作为癌症和多克索鲁比诱导的心脏毒性之间的分子桥梁.
- AM106对抗米尔是一种有前途的治疗药物,用于心脏瘤学,提供瘤控制和心脏保护.
- 人工智能驱动的分析可以增强个性化治疗和癌症患者的风险分层.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


